GCG and diabetes mellitus: Treatments designed to inhibit glucagon-GCGR interaction, such as GCGR antisense oligonucleotides, small-molecule GCGR antagonists, and GCGR-antagonizing antibodies, have demonstrated various benefits on diabetes in mice and primates [8]–[14].